Acromegaly Completed Phase 2 Trials for Pasireotide (DB06663)

Back to Acromegaly

Also known as: Acromegalic / Acromegaly (disorder)

IndicationStatusPhase
DBCOND0000951 (Acromegaly)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01673646
Efficacy and Safety of Pasireotide LAR (Long-acting Release) in Japanese Patients With Acromegaly or Pituitary GigantismTreatment
NCT00171730
An Extension Study to Assess the Long-Term Safety and Efficacy of Pasireotide in Participants With AcromegalyTreatment
NCT00088582
Study Comparing SOM230 Subcutaneously and Sandostatin Subcutaneously in Acromegalic PatientsTreatment